nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—Rash macular—Temsirolimus—kidney cancer	0.0418	0.0445	CcSEcCtD
Bretylium—Rash macular—Pazopanib—kidney cancer	0.0393	0.0419	CcSEcCtD
Bretylium—Edrophonium—ACHE—kidney cancer	0.0387	0.63	CrCbGaD
Bretylium—Rash macular—Everolimus—kidney cancer	0.0311	0.0331	CcSEcCtD
Bretylium—Rash macular—Sunitinib—kidney cancer	0.0259	0.0276	CcSEcCtD
Bretylium—Edrophonium—BCHE—kidney cancer	0.0228	0.37	CrCbGaD
Bretylium—Rash macular—Paclitaxel—kidney cancer	0.0174	0.0186	CcSEcCtD
Bretylium—Hiccups—Pazopanib—kidney cancer	0.0161	0.0172	CcSEcCtD
Bretylium—Rash macular—Capecitabine—kidney cancer	0.0143	0.0152	CcSEcCtD
Bretylium—Tenderness—Erlotinib—kidney cancer	0.0141	0.015	CcSEcCtD
Bretylium—Lethargy—Pazopanib—kidney cancer	0.012	0.0127	CcSEcCtD
Bretylium—Nasal congestion—Everolimus—kidney cancer	0.0102	0.0108	CcSEcCtD
Bretylium—Tenderness—Gemcitabine—kidney cancer	0.00979	0.0104	CcSEcCtD
Bretylium—Lethargy—Everolimus—kidney cancer	0.00944	0.0101	CcSEcCtD
Bretylium—Conjunctivitis—Temsirolimus—kidney cancer	0.00932	0.00993	CcSEcCtD
Bretylium—Nasal congestion—Sunitinib—kidney cancer	0.00848	0.00904	CcSEcCtD
Bretylium—Bradycardia—Pazopanib—kidney cancer	0.00825	0.00879	CcSEcCtD
Bretylium—Tenderness—Paclitaxel—kidney cancer	0.0082	0.00873	CcSEcCtD
Bretylium—Ventricular extrasystoles—Paclitaxel—kidney cancer	0.00792	0.00844	CcSEcCtD
Bretylium—Angina pectoris—Vinblastine—kidney cancer	0.00782	0.00833	CcSEcCtD
Bretylium—Angina pectoris—Everolimus—kidney cancer	0.00779	0.0083	CcSEcCtD
Bretylium—Mood swings—Sorafenib—kidney cancer	0.00761	0.00811	CcSEcCtD
Bretylium—Flushing—Pazopanib—kidney cancer	0.00752	0.00801	CcSEcCtD
Bretylium—Lethargy—Dactinomycin—kidney cancer	0.00746	0.00795	CcSEcCtD
Bretylium—Conjunctivitis—Everolimus—kidney cancer	0.00693	0.00738	CcSEcCtD
Bretylium—Conjunctivitis—Erlotinib—kidney cancer	0.00669	0.00712	CcSEcCtD
Bretylium—Ventricular extrasystoles—Capecitabine—kidney cancer	0.0065	0.00692	CcSEcCtD
Bretylium—Hypertension—Temsirolimus—kidney cancer	0.00647	0.00689	CcSEcCtD
Bretylium—Lightheadedness—Paclitaxel—kidney cancer	0.0064	0.00682	CcSEcCtD
Bretylium—Anxiety—Temsirolimus—kidney cancer	0.00635	0.00677	CcSEcCtD
Bretylium—Syncope—Pazopanib—kidney cancer	0.00633	0.00674	CcSEcCtD
Bretylium—Loss of consciousness—Pazopanib—kidney cancer	0.0062	0.00661	CcSEcCtD
Bretylium—Hypertension—Pazopanib—kidney cancer	0.00609	0.00649	CcSEcCtD
Bretylium—Flushing—Everolimus—kidney cancer	0.00594	0.00633	CcSEcCtD
Bretylium—Hiccups—Capecitabine—kidney cancer	0.00587	0.00625	CcSEcCtD
Bretylium—Nasal congestion—Paclitaxel—kidney cancer	0.0057	0.00607	CcSEcCtD
Bretylium—Shock—Pazopanib—kidney cancer	0.00567	0.00604	CcSEcCtD
Bretylium—Hyperhidrosis—Pazopanib—kidney cancer	0.00557	0.00593	CcSEcCtD
Bretylium—Dyspnoea—Temsirolimus—kidney cancer	0.00545	0.00581	CcSEcCtD
Bretylium—Bradycardia—Sunitinib—kidney cancer	0.00544	0.0058	CcSEcCtD
Bretylium—Lethargy—Paclitaxel—kidney cancer	0.0053	0.00564	CcSEcCtD
Bretylium—Flushing—Sorafenib—kidney cancer	0.00516	0.00549	CcSEcCtD
Bretylium—Dyspnoea—Pazopanib—kidney cancer	0.00513	0.00547	CcSEcCtD
Bretylium—Vertigo—Vinblastine—kidney cancer	0.00502	0.00535	CcSEcCtD
Bretylium—Gastrointestinal pain—Temsirolimus—kidney cancer	0.005	0.00533	CcSEcCtD
Bretylium—Syncope—Everolimus—kidney cancer	0.005	0.00532	CcSEcCtD
Bretylium—Flushing—Sunitinib—kidney cancer	0.00496	0.00529	CcSEcCtD
Bretylium—Mood swings—Paclitaxel—kidney cancer	0.00492	0.00524	CcSEcCtD
Bretylium—Loss of consciousness—Everolimus—kidney cancer	0.0049	0.00522	CcSEcCtD
Bretylium—Body temperature increased—Temsirolimus—kidney cancer	0.00483	0.00515	CcSEcCtD
Bretylium—Abdominal pain—Temsirolimus—kidney cancer	0.00483	0.00515	CcSEcCtD
Bretylium—Hypertension—Vinblastine—kidney cancer	0.00483	0.00514	CcSEcCtD
Bretylium—Syncope—Erlotinib—kidney cancer	0.00482	0.00514	CcSEcCtD
Bretylium—Hypertension—Everolimus—kidney cancer	0.00481	0.00512	CcSEcCtD
Bretylium—Orthostatic hypotension—Paclitaxel—kidney cancer	0.00474	0.00505	CcSEcCtD
Bretylium—Anxiety—Everolimus—kidney cancer	0.00473	0.00504	CcSEcCtD
Bretylium—Loss of consciousness—Erlotinib—kidney cancer	0.00472	0.00503	CcSEcCtD
Bretylium—Gastrointestinal pain—Pazopanib—kidney cancer	0.00471	0.00502	CcSEcCtD
Bretylium—Flushing—Dactinomycin—kidney cancer	0.0047	0.005	CcSEcCtD
Bretylium—Anxiety—Erlotinib—kidney cancer	0.00456	0.00486	CcSEcCtD
Bretylium—Abdominal pain—Pazopanib—kidney cancer	0.00455	0.00485	CcSEcCtD
Bretylium—Shock—Everolimus—kidney cancer	0.00447	0.00477	CcSEcCtD
Bretylium—Hyperhidrosis—Everolimus—kidney cancer	0.0044	0.00468	CcSEcCtD
Bretylium—Sweating increased—Paclitaxel—kidney cancer	0.00437	0.00466	CcSEcCtD
Bretylium—Lethargy—Capecitabine—kidney cancer	0.00435	0.00463	CcSEcCtD
Bretylium—Syncope—Sorafenib—kidney cancer	0.00434	0.00462	CcSEcCtD
Bretylium—Shock—Erlotinib—kidney cancer	0.00432	0.0046	CcSEcCtD
Bretylium—Loss of consciousness—Sorafenib—kidney cancer	0.00425	0.00453	CcSEcCtD
Bretylium—Ventricular extrasystoles—Doxorubicin—kidney cancer	0.00419	0.00446	CcSEcCtD
Bretylium—Diarrhoea—Temsirolimus—kidney cancer	0.00418	0.00446	CcSEcCtD
Bretylium—Hypertension—Sorafenib—kidney cancer	0.00418	0.00445	CcSEcCtD
Bretylium—Dyspnoea—Everolimus—kidney cancer	0.00405	0.00432	CcSEcCtD
Bretylium—Dizziness—Temsirolimus—kidney cancer	0.00404	0.00431	CcSEcCtD
Bretylium—Mood swings—Capecitabine—kidney cancer	0.00404	0.0043	CcSEcCtD
Bretylium—Hypertension—Sunitinib—kidney cancer	0.00402	0.00428	CcSEcCtD
Bretylium—Diarrhoea—Pazopanib—kidney cancer	0.00394	0.0042	CcSEcCtD
Bretylium—Dyspnoea—Erlotinib—kidney cancer	0.00391	0.00417	CcSEcCtD
Bretylium—Orthostatic hypotension—Capecitabine—kidney cancer	0.00389	0.00415	CcSEcCtD
Bretylium—Conjunctivitis—Paclitaxel—kidney cancer	0.00389	0.00414	CcSEcCtD
Bretylium—Vomiting—Temsirolimus—kidney cancer	0.00389	0.00414	CcSEcCtD
Bretylium—Shock—Sorafenib—kidney cancer	0.00388	0.00414	CcSEcCtD
Bretylium—Dizziness—Pazopanib—kidney cancer	0.00381	0.00406	CcSEcCtD
Bretylium—Hiccups—Doxorubicin—kidney cancer	0.00378	0.00403	CcSEcCtD
Bretylium—Feeling abnormal—Vinblastine—kidney cancer	0.00376	0.00401	CcSEcCtD
Bretylium—Feeling abnormal—Everolimus—kidney cancer	0.00375	0.00399	CcSEcCtD
Bretylium—Shock—Sunitinib—kidney cancer	0.00374	0.00398	CcSEcCtD
Bretylium—Gastrointestinal pain—Vinblastine—kidney cancer	0.00373	0.00398	CcSEcCtD
Bretylium—Gastrointestinal pain—Everolimus—kidney cancer	0.00372	0.00396	CcSEcCtD
Bretylium—Vomiting—Pazopanib—kidney cancer	0.00366	0.0039	CcSEcCtD
Bretylium—Bradycardia—Paclitaxel—kidney cancer	0.00366	0.0039	CcSEcCtD
Bretylium—Nausea—Temsirolimus—kidney cancer	0.00363	0.00387	CcSEcCtD
Bretylium—Abdominal pain—Vinblastine—kidney cancer	0.00361	0.00384	CcSEcCtD
Bretylium—Abdominal pain—Everolimus—kidney cancer	0.00359	0.00383	CcSEcCtD
Bretylium—Body temperature increased—Everolimus—kidney cancer	0.00359	0.00383	CcSEcCtD
Bretylium—Gastrointestinal pain—Erlotinib—kidney cancer	0.00359	0.00382	CcSEcCtD
Bretylium—Angina pectoris—Capecitabine—kidney cancer	0.00359	0.00382	CcSEcCtD
Bretylium—Sweating increased—Capecitabine—kidney cancer	0.00359	0.00382	CcSEcCtD
Bretylium—Vertigo—Vincristine—kidney cancer	0.00354	0.00377	CcSEcCtD
Bretylium—Dyspnoea—Sorafenib—kidney cancer	0.00352	0.00375	CcSEcCtD
Bretylium—Abdominal pain—Erlotinib—kidney cancer	0.00347	0.0037	CcSEcCtD
Bretylium—Body temperature increased—Erlotinib—kidney cancer	0.00347	0.0037	CcSEcCtD
Bretylium—Nausea—Pazopanib—kidney cancer	0.00342	0.00364	CcSEcCtD
Bretylium—Hypertension—Vincristine—kidney cancer	0.0034	0.00362	CcSEcCtD
Bretylium—Dyspnoea—Sunitinib—kidney cancer	0.00339	0.00361	CcSEcCtD
Bretylium—Flushing—Paclitaxel—kidney cancer	0.00333	0.00355	CcSEcCtD
Bretylium—Gastrointestinal pain—Sorafenib—kidney cancer	0.00323	0.00344	CcSEcCtD
Bretylium—Hypertension—Gemcitabine—kidney cancer	0.00322	0.00343	CcSEcCtD
Bretylium—Conjunctivitis—Capecitabine—kidney cancer	0.00319	0.0034	CcSEcCtD
Bretylium—Diarrhoea—Vinblastine—kidney cancer	0.00312	0.00333	CcSEcCtD
Bretylium—Body temperature increased—Sorafenib—kidney cancer	0.00312	0.00332	CcSEcCtD
Bretylium—Abdominal pain—Sorafenib—kidney cancer	0.00312	0.00332	CcSEcCtD
Bretylium—Diarrhoea—Everolimus—kidney cancer	0.00311	0.00331	CcSEcCtD
Bretylium—Gastrointestinal pain—Sunitinib—kidney cancer	0.00311	0.00331	CcSEcCtD
Bretylium—Hyperhidrosis—Vincristine—kidney cancer	0.00311	0.00331	CcSEcCtD
Bretylium—Dizziness—Vinblastine—kidney cancer	0.00302	0.00322	CcSEcCtD
Bretylium—Dizziness—Everolimus—kidney cancer	0.00301	0.0032	CcSEcCtD
Bretylium—Body temperature increased—Sunitinib—kidney cancer	0.003	0.0032	CcSEcCtD
Bretylium—Abdominal pain—Sunitinib—kidney cancer	0.003	0.0032	CcSEcCtD
Bretylium—Diarrhoea—Erlotinib—kidney cancer	0.003	0.0032	CcSEcCtD
Bretylium—Bradycardia—Capecitabine—kidney cancer	0.003	0.0032	CcSEcCtD
Bretylium—Feeling abnormal—Dactinomycin—kidney cancer	0.00296	0.00316	CcSEcCtD
Bretylium—Hyperhidrosis—Gemcitabine—kidney cancer	0.00295	0.00314	CcSEcCtD
Bretylium—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00294	0.00313	CcSEcCtD
Bretylium—Vomiting—Vinblastine—kidney cancer	0.0029	0.00309	CcSEcCtD
Bretylium—Dizziness—Erlotinib—kidney cancer	0.0029	0.00309	CcSEcCtD
Bretylium—Vomiting—Everolimus—kidney cancer	0.00289	0.00308	CcSEcCtD
Bretylium—Abdominal pain—Dactinomycin—kidney cancer	0.00284	0.00303	CcSEcCtD
Bretylium—Body temperature increased—Dactinomycin—kidney cancer	0.00284	0.00303	CcSEcCtD
Bretylium—Vertigo—Paclitaxel—kidney cancer	0.00281	0.00299	CcSEcCtD
Bretylium—Syncope—Paclitaxel—kidney cancer	0.0028	0.00299	CcSEcCtD
Bretylium—Lethargy—Doxorubicin—kidney cancer	0.0028	0.00299	CcSEcCtD
Bretylium—Vomiting—Erlotinib—kidney cancer	0.00279	0.00297	CcSEcCtD
Bretylium—Loss of consciousness—Paclitaxel—kidney cancer	0.00275	0.00293	CcSEcCtD
Bretylium—Flushing—Capecitabine—kidney cancer	0.00273	0.00291	CcSEcCtD
Bretylium—Dyspnoea—Gemcitabine—kidney cancer	0.00272	0.00289	CcSEcCtD
Bretylium—Nausea—Vinblastine—kidney cancer	0.00271	0.00289	CcSEcCtD
Bretylium—Affect lability—Doxorubicin—kidney cancer	0.0027	0.00288	CcSEcCtD
Bretylium—Nausea—Everolimus—kidney cancer	0.0027	0.00288	CcSEcCtD
Bretylium—Diarrhoea—Sorafenib—kidney cancer	0.0027	0.00288	CcSEcCtD
Bretylium—Hypertension—Paclitaxel—kidney cancer	0.0027	0.00288	CcSEcCtD
Bretylium—Anxiety—Paclitaxel—kidney cancer	0.00265	0.00283	CcSEcCtD
Bretylium—Gastrointestinal pain—Vincristine—kidney cancer	0.00263	0.0028	CcSEcCtD
Bretylium—Dizziness—Sorafenib—kidney cancer	0.00261	0.00278	CcSEcCtD
Bretylium—Nausea—Erlotinib—kidney cancer	0.00261	0.00278	CcSEcCtD
Bretylium—Mood swings—Doxorubicin—kidney cancer	0.0026	0.00277	CcSEcCtD
Bretylium—Diarrhoea—Sunitinib—kidney cancer	0.0026	0.00277	CcSEcCtD
Bretylium—Confusional state—Paclitaxel—kidney cancer	0.00257	0.00274	CcSEcCtD
Bretylium—Abdominal pain—Vincristine—kidney cancer	0.00254	0.00271	CcSEcCtD
Bretylium—Body temperature increased—Vincristine—kidney cancer	0.00254	0.00271	CcSEcCtD
Bretylium—Dizziness—Sunitinib—kidney cancer	0.00251	0.00268	CcSEcCtD
Bretylium—Feeling abnormal—Gemcitabine—kidney cancer	0.00251	0.00268	CcSEcCtD
Bretylium—Shock—Paclitaxel—kidney cancer	0.00251	0.00267	CcSEcCtD
Bretylium—Vomiting—Sorafenib—kidney cancer	0.00251	0.00267	CcSEcCtD
Bretylium—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00251	0.00267	CcSEcCtD
Bretylium—Hyperhidrosis—Paclitaxel—kidney cancer	0.00247	0.00263	CcSEcCtD
Bretylium—Diarrhoea—Dactinomycin—kidney cancer	0.00246	0.00262	CcSEcCtD
Bretylium—Vomiting—Sunitinib—kidney cancer	0.00241	0.00257	CcSEcCtD
Bretylium—Body temperature increased—Gemcitabine—kidney cancer	0.00241	0.00257	CcSEcCtD
Bretylium—Nausea—Sorafenib—kidney cancer	0.00234	0.0025	CcSEcCtD
Bretylium—Angina pectoris—Doxorubicin—kidney cancer	0.00231	0.00246	CcSEcCtD
Bretylium—Vertigo—Capecitabine—kidney cancer	0.0023	0.00246	CcSEcCtD
Bretylium—Syncope—Capecitabine—kidney cancer	0.0023	0.00245	CcSEcCtD
Bretylium—Vomiting—Dactinomycin—kidney cancer	0.00229	0.00244	CcSEcCtD
Bretylium—Dyspnoea—Paclitaxel—kidney cancer	0.00227	0.00242	CcSEcCtD
Bretylium—Nausea—Sunitinib—kidney cancer	0.00226	0.0024	CcSEcCtD
Bretylium—Loss of consciousness—Capecitabine—kidney cancer	0.00225	0.0024	CcSEcCtD
Bretylium—Hypertension—Capecitabine—kidney cancer	0.00221	0.00236	CcSEcCtD
Bretylium—Diarrhoea—Vincristine—kidney cancer	0.0022	0.00234	CcSEcCtD
Bretylium—Anxiety—Capecitabine—kidney cancer	0.00218	0.00232	CcSEcCtD
Bretylium—Nausea—Dactinomycin—kidney cancer	0.00214	0.00228	CcSEcCtD
Bretylium—Dizziness—Vincristine—kidney cancer	0.00212	0.00226	CcSEcCtD
Bretylium—Confusional state—Capecitabine—kidney cancer	0.00211	0.00225	CcSEcCtD
Bretylium—Feeling abnormal—Paclitaxel—kidney cancer	0.0021	0.00224	CcSEcCtD
Bretylium—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00209	0.00222	CcSEcCtD
Bretylium—Diarrhoea—Gemcitabine—kidney cancer	0.00208	0.00222	CcSEcCtD
Bretylium—Shock—Capecitabine—kidney cancer	0.00206	0.00219	CcSEcCtD
Bretylium—Conjunctivitis—Doxorubicin—kidney cancer	0.00206	0.00219	CcSEcCtD
Bretylium—Vomiting—Vincristine—kidney cancer	0.00204	0.00218	CcSEcCtD
Bretylium—Hyperhidrosis—Capecitabine—kidney cancer	0.00202	0.00216	CcSEcCtD
Bretylium—Abdominal pain—Paclitaxel—kidney cancer	0.00202	0.00215	CcSEcCtD
Bretylium—Body temperature increased—Paclitaxel—kidney cancer	0.00202	0.00215	CcSEcCtD
Bretylium—Vomiting—Gemcitabine—kidney cancer	0.00194	0.00206	CcSEcCtD
Bretylium—Bradycardia—Doxorubicin—kidney cancer	0.00193	0.00206	CcSEcCtD
Bretylium—Nausea—Vincristine—kidney cancer	0.00191	0.00203	CcSEcCtD
Bretylium—Dyspnoea—Capecitabine—kidney cancer	0.00187	0.00199	CcSEcCtD
Bretylium—Nausea—Gemcitabine—kidney cancer	0.00181	0.00193	CcSEcCtD
Bretylium—Flushing—Doxorubicin—kidney cancer	0.00176	0.00188	CcSEcCtD
Bretylium—Diarrhoea—Paclitaxel—kidney cancer	0.00175	0.00186	CcSEcCtD
Bretylium—Feeling abnormal—Capecitabine—kidney cancer	0.00173	0.00184	CcSEcCtD
Bretylium—Gastrointestinal pain—Capecitabine—kidney cancer	0.00171	0.00182	CcSEcCtD
Bretylium—Dizziness—Paclitaxel—kidney cancer	0.00169	0.0018	CcSEcCtD
Bretylium—Abdominal pain—Capecitabine—kidney cancer	0.00166	0.00176	CcSEcCtD
Bretylium—Body temperature increased—Capecitabine—kidney cancer	0.00166	0.00176	CcSEcCtD
Bretylium—Vomiting—Paclitaxel—kidney cancer	0.00162	0.00173	CcSEcCtD
Bretylium—Nausea—Paclitaxel—kidney cancer	0.00152	0.00161	CcSEcCtD
Bretylium—Vertigo—Doxorubicin—kidney cancer	0.00149	0.00158	CcSEcCtD
Bretylium—Syncope—Doxorubicin—kidney cancer	0.00148	0.00158	CcSEcCtD
Bretylium—Loss of consciousness—Doxorubicin—kidney cancer	0.00145	0.00155	CcSEcCtD
Bretylium—Diarrhoea—Capecitabine—kidney cancer	0.00143	0.00153	CcSEcCtD
Bretylium—Hypertension—Doxorubicin—kidney cancer	0.00143	0.00152	CcSEcCtD
Bretylium—Anxiety—Doxorubicin—kidney cancer	0.0014	0.00149	CcSEcCtD
Bretylium—Dizziness—Capecitabine—kidney cancer	0.00138	0.00148	CcSEcCtD
Bretylium—Confusional state—Doxorubicin—kidney cancer	0.00136	0.00145	CcSEcCtD
Bretylium—Vomiting—Capecitabine—kidney cancer	0.00133	0.00142	CcSEcCtD
Bretylium—Shock—Doxorubicin—kidney cancer	0.00133	0.00141	CcSEcCtD
Bretylium—Hyperhidrosis—Doxorubicin—kidney cancer	0.0013	0.00139	CcSEcCtD
Bretylium—Nausea—Capecitabine—kidney cancer	0.00124	0.00133	CcSEcCtD
Bretylium—Dyspnoea—Doxorubicin—kidney cancer	0.0012	0.00128	CcSEcCtD
Bretylium—Feeling abnormal—Doxorubicin—kidney cancer	0.00111	0.00118	CcSEcCtD
Bretylium—Gastrointestinal pain—Doxorubicin—kidney cancer	0.0011	0.00118	CcSEcCtD
Bretylium—Body temperature increased—Doxorubicin—kidney cancer	0.00107	0.00114	CcSEcCtD
Bretylium—Abdominal pain—Doxorubicin—kidney cancer	0.00107	0.00114	CcSEcCtD
Bretylium—Diarrhoea—Doxorubicin—kidney cancer	0.000923	0.000984	CcSEcCtD
Bretylium—Dizziness—Doxorubicin—kidney cancer	0.000892	0.000951	CcSEcCtD
Bretylium—Vomiting—Doxorubicin—kidney cancer	0.000858	0.000914	CcSEcCtD
Bretylium—Nausea—Doxorubicin—kidney cancer	0.000802	0.000854	CcSEcCtD
